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FPIN's Clinical Inquiries 
Counseling or Antidepressants for Treating Depression? 
Clinical Question 
In adults with depression, is treatment with antidepressants more effective than counseling? 
Evidence-Based Answer 
Both antidepressant medications and psychologic treatment are beneficial for adult patients with 
mild to moderate depression, with no consistent evidence that one type of treatment is more 
effective than the other. [Strength of recommendation: A, based on randomized controlled trials 
(RCTs) and systematic reviews] 
There is limited evidence that antidepressant medications and cognitive behavioral therapy are 
similarly effective for patients with severe depression [Strength of recommendation: B, based on 
a single RCT] 
Evidence Summary 
By 2020, depression is expected to be the second most common cause of disability worldwide.1 
Current numbers show that major depression will affect 4.9 to 17.9 percent of U.S. residents 
sometime during their lifetimes; 20 to 30 percent of this group will experience a chronic, 
relapsing course.2 Ninety percent of depression is treated by primary care physicians.3 
For adults with mild to moderate depression, there is no direct evidence that drug or nondrug 
therapy is superior. Prescription antidepressants are effective at all levels of severity, but 
systematic reviews have shown no differences in outcomes between any classes of 
antidepressants.4 Different types of psychotherapy (including cognitive therapy and 
interpersonal psychotherapy) are also effective for managing mild to moderate depression.1 
However, consistent evidence is lacking to make a statement about the relative effectiveness of 
different types of psychotherapies compared with each other or with drug treatment. One RCT5 
comparing nefazodone (Serzone, removed from the U.S. market in May 2004 because of 
hepatotoxicity) with cognitive behavioral therapy over a 12-week period demonstrated similar 
effectiveness for each treatment alone. Another RCT6 of 240 outpatients with moderate to severe 
depression compared the effectiveness of paroxetine (Paxil) and other medications with 
cognitive behavioral therapy. Both treatment types were found to be effective, but the degree of 
effectiveness for cognitive behavioral therapy was dependent on therapist experience, and the 
overall number of patients in the therapy group was small (n = 60).6 
An evidence report4 from the Agency for Healthcare Research and Quality states that data are 
too limited to determine if newer antidepressants are more or less effective than psychosocial 
therapies. Options for pharmacologic and psychotherapeutic treatment of resistant depression 
(i.e., depression that has not remitted after a first-line drug therapy) are the subject of the 
Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial,2 with results expected 
in 2006. 
Recommendations from Others 
The Institute for Clinical Systems Improvement states in an evidence-based guideline that mild 
to moderate depression can be treated with psychotherapy instead of, or in addition to, 
pharmacotherapy.7 The guideline also states that cognitive behavioral therapy, interpersonal 
therapy, and antidepressant medications are equally effective in treating mild to moderate levels 
of major depression.7 The Veterans Health Administration clinical practice guideline states that 
psychotherapy generally is an appropriate treatment for all forms of depression managed in the 
primary care setting, and that because there are no demonstrated differences in treatment 
outcomes between pharmacotherapy and psychotherapy, patient choice should be strongly 
considered in treatment planning.8 
Clinical Commentary 
The appropriate treatment of depression is of special interest to primary care physicians, who 
treat the majority of this illness. Although it is reassuring that both antidepressant medication and 
psychological treatments are effective for patients with mild to moderate disease, physicians are 
left with the practical consideration of choosing which therapy to use, knowing that neither has 
yet been shown to be superior. Individualizing the treatment decision requires consideration of 
local psychotherapy resources, relative expense of treatments, insurance coverage, and response 
to past therapies. Both patient and physician preferences are appropriate factors to consider when 
planning treatment for depression. 
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